SCHEMBL6063192

SCHEMBL6063192

N#C[C@@H](CC(N)=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
PKM P14618 1/20 0.44
TSHR P16473 1/20 0.44
SLC6A3 Q01959 3/20 0.43
DRD3 P35462 2/20 0.43
LMNA P02545 2/20 0.43
ADORA3 P0DMS8 1/20 0.43
EDNRB P24530 1/20 0.43
MAPK1 P28482 1/20 0.43
MC4R P32245 1/20 0.43
MC3R P41968 1/20 0.43
DRD2 P14416 1/20 0.43
GABBR2 O75899 1/20 0.42
GABBR1 Q9UBS5 1/20 0.42
TNF P01375 1/20 0.42
ALDH1A1 P00352 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6798718 1.00 CYP2C19 (0.47) CYP2C19SMN1; SMN2NPSR1CYP1A2CYP2D6
SCHEMBL1343883 0.85 FFAR1 (0.51) CYP2C19CYP2D6TSHRGABBR2GABBR1
SCHEMBL27862777 0.85 FFAR1 (0.51) CYP2C19CYP2D6TSHRGABBR2GABBR1
SCHEMBL9556420 0.85 FFAR1 (0.51) CYP2C19CYP2D6TSHRGABBR2GABBR1
SCHEMBL6801487 0.84 ESR1 (0.56) CYP2C19CYP1A2TSHRALDH1A1KMT2A
SCHEMBL1754734 0.81 TSHR (0.53) CYP2C19SMN1; SMN2NPSR1CYP1A2TSHR
SCHEMBL31326025 0.81 TSHR (0.53) CYP2C19SMN1; SMN2NPSR1CYP1A2TSHR
SCHEMBL11568787 0.81 KMT2A (0.46) SMN1; SMN2NPSR1TSHRLMNAGABBR2
SCHEMBL3055864 0.81 TSHR (0.44) CYP2C19SMN1; SMN2NPSR1CYP1A2CYP2D6
SCHEMBL3956408 0.81 CYP1A2 (0.62) CYP2C19SMN1; SMN2NPSR1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1397340-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-03-17 EP claimed
WO-2002098850-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2002-12-12 WO claimed
EP-1694357-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2006-08-30 EP disclosed
WO-2005058348-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2005-06-30 WO disclosed
EP-1397340-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-03-17 EP disclosed
WO-2002098850-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2002-12-12 WO disclosed